Article info
Original research
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups
- Correspondence to Dr Gabriella Macchia, Radiation Oncology Unit, Gemelli Molise, Campobasso 86100, Molise, Italy; macchiagabriella{at}gmail.com
Citation
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups
Publication history
- Received November 17, 2021
- Accepted February 3, 2022
- First published February 22, 2022.
Online issue publication
June 06, 2022
Article Versions
- Previous version (22 February 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.